Live News Reader

Some of the articles presented on this website are accessed through RSS feeds from third-party sources that are not necessarily part of the Histiocytosis Association. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the Histiocytosis Association.

If you know of a histio-related article that isn't shown here, please send the article to outreach@histio.org.

"Erdheim-Chester disease" - Google News
Erdheim-Chester disease: Treatment options after diagnosis | Health - PostBulletin.com
Erdheim-Chester disease: Treatment options after diagnosis | Health  PostBulletin.com

Doctors Ronald Go and Gaurav Goyal discuss what patients can expect after they receive a diagnosis of Erdheim-Chester disease. Treatment options can range ...


Monday, August 19, 2019 12:16:26 PM

Erdheim-Chester Disease: What is it and what are the signs and symptoms? - PostBulletin.com
Erdheim-Chester Disease: What is it and what are the signs and symptoms?  PostBulletin.com

Erdheim-Chester disease is a very rare disorder in which histiocytes, cells that help fight infection, multiply and infiltrate bone marrow and then spread ...


Tuesday, August 06, 2019 3:00:00 AM

Erdheim-Chester Disease Market to Hold a High Potential for Growth by 2028 - dailychronicle24.com
Erdheim-Chester Disease Market to Hold a High Potential for Growth by 2028  dailychronicle24.com

Erdheim-Chester disease (ECD) is a rare disease which occurs in adults. It is identified by excessive accumulation and production of histiocytes (white blood ...


Thursday, August 08, 2019 4:51:00 AM

Erdheim-Chester disease: Finding a specialist and long-term monitoring - PostBulletin.com
Erdheim-Chester disease: Finding a specialist and long-term monitoring  PostBulletin.com

Erdheim-Chester disease is a very rare disorder in which histiocytes, cells that help fight infection, multiply and infiltrate bone marrow and then spread ...


Wednesday, August 14, 2019 11:00:35 AM

CNS Abnormalities Common in Erdheim-Chester Disease - Neurology Advisor
CNS Abnormalities Common in Erdheim-Chester Disease  Neurology Advisor

Patients with Erdheim-Chester disease (ECD) are at risk for a variety of central nervous system (CNS) abnormalities, and brain and spine magnetic resonance ...


Friday, February 23, 2018 3:00:00 AM

Genes associated with Erdheim-Chester disease also linked to cancer - Medical Xpress
Genes associated with Erdheim-Chester disease also linked to cancer  Medical Xpress

National Human Genome Research Institute (NHGRI) researchers have identified new genes associated with the Erdheim-Chester disease (ECD) and some ...


Friday, March 31, 2017 3:00:00 AM

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer - FDA.gov
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer  FDA.gov

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with ...


Monday, November 06, 2017 3:00:00 AM

18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker - Journal of Nuclear Medicine
18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker  Journal of Nuclear Medicine

+ Author Affiliations. 1Department of Radiology, Mayo Clinic, Rochester, Minnesota. 2Department of Immunology, Mayo Clinic, Rochester, Minnesota; and.


Thursday, November 02, 2017 3:00:00 AM

FDA Approves Vemurafenib for Treating Erdheim-Chester Disease - Cancer Network
FDA Approves Vemurafenib for Treating Erdheim-Chester Disease  Cancer Network

The FDA has expanded the approval of vemurafenib (Zelboraf) to include the treatment of Erdheim–Chester disease in adult BRAF V600–positive patients.


Thursday, November 09, 2017 3:00:00 AM

Vemurafenib Effective in BRAF-mutated Erdheim-Chester Disease and Langerhans Cell Histiocytosis - Cancer Therapy Advisor
Vemurafenib Effective in BRAF-mutated Erdheim-Chester Disease and Langerhans Cell Histiocytosis  Cancer Therapy Advisor

Vemurafenib confers a durable and clinically beneficial effect among patients with BRAF-mutant Erdheim-Chester disease (ECD) or Langerhans cell ...


Thursday, November 30, 2017 3:00:00 AM

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
| info@histio.org
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Follow Me on Pinterest   


¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: outreach@histio.org. Nosotros podremos responderle tan pronto nos sea possible. Gracias!